Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like Shocker: Life-Saving Portable Defibrillator Movement Plagued By Malfunctions March 30, 2017 Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target March 21, 2017 2 Under-the-Radar Pharma M&A Targets for 2018 January 10, 2018
Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target March 21, 2017
